Business Description
HBM Holdings Ltd
ISIN : KYG4403H1002
Share Class Description:
FRA:6XY: Ordinary SharesCompare
Compare
Traded in other countries / regions
02142.Hong Kong6XY.GermanyHBMHF.USA IPO Date
2021-02-02Description
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the United States.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.77 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.54 | |||||
| Debt-to-EBITDA | 2.32 | |||||
| Interest Coverage | 5.98 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.29 | |||||
| Beneish M-Score | -0.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.8 | |||||
| 3-Year FCF Growth Rate | 47.7 | |||||
| 3-Year Book Growth Rate | -30.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.43 | |||||
| 9-Day RSI | 74.63 | |||||
| 14-Day RSI | 67.04 | |||||
| 6-1 Month Momentum % | -0.79 | |||||
| 12-1 Month Momentum % | -17.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.45 | |||||
| Quick Ratio | 3.44 | |||||
| Cash Ratio | 3.12 | |||||
| Days Inventory | 92.45 | |||||
| Days Sales Outstanding | 102.79 | |||||
| Days Payable | 1415.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 15.38 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 95.57 | |||||
| Operating Margin % | 25.54 | |||||
| Net Margin % | 29.5 | |||||
| FCF Margin % | 28.5 | |||||
| ROE % | 18.57 | |||||
| ROA % | 9.5 | |||||
| ROIC % | 28.65 | |||||
| ROC (Joel Greenblatt) % | 158.43 | |||||
| ROCE % | 15.22 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 6.65 | |||||
| PE Ratio without NRI | 6.65 | |||||
| PS Ratio | 1.91 | |||||
| PB Ratio | 1.11 | |||||
| Price-to-Tangible-Book | 1.23 | |||||
| Price-to-Free-Cash-Flow | 6.74 | |||||
| Price-to-Operating-Cash-Flow | 6.44 | |||||
| EV-to-EBIT | 0.79 | |||||
| EV-to-Forward-EBIT | -0.84 | |||||
| EV-to-EBITDA | 0.68 | |||||
| EV-to-Forward-EBITDA | -0.86 | |||||
| EV-to-Revenue | 0.27 | |||||
| EV-to-Forward-Revenue | 1.42 | |||||
| EV-to-FCF | 0.96 | |||||
| Price-to-Graham-Number | 0.59 | |||||
| Price-to-Net-Current-Asset-Value | 1.23 | |||||
| Price-to-Net-Cash | 1.5 | |||||
| Earnings Yield (Greenblatt) % | 126.58 | |||||
| FCF Yield % | 14.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HBM Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 66.498 | ||
| EPS (TTM) (€) | 0.026 | ||
| Beta | 1.03 | ||
| Volatility % | 59.61 | ||
| 14-Day RSI | 67.04 | ||
| 14-Day ATR (€) | 0.004295 | ||
| 20-Day SMA (€) | 0.11675 | ||
| 12-1 Month Momentum % | -17.22 | ||
| 52-Week Range (€) | 0.0965 - 0.186 | ||
| Shares Outstanding (Mil) | 730.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HBM Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HBM Holdings Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
HBM Holdings Ltd Frequently Asked Questions
What is HBM Holdings Ltd(FRA:6XY)'s stock price today?
The current price of FRA:6XY is €0.14. The 52 week high of FRA:6XY is €0.19 and 52 week low is €0.10.
When is next earnings date of HBM Holdings Ltd(FRA:6XY)?
The next earnings date of HBM Holdings Ltd(FRA:6XY) is 2025-03-16 Est..
Does HBM Holdings Ltd(FRA:6XY) pay dividends? If so, how much?
HBM Holdings Ltd(FRA:6XY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers